Sort
48,018 grants matching “immunotherapy”
Duke SPORE in Brain Cancer
$1,432,302John H Sampson · Duke University · P50 · FY2021 · CA
LIAI Epitope Validation Center: Characterization of Allergen specific T Cells
$1,431,765Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2015 · AI
Clinical Trials of Patients with AIDS-Related Malignancies
$1,431,643Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases
$1,431,221Melanie Hayden Gephart · Stanford University · U54 · FY2024 · CA
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
$1,430,472David E Fisher · Massachusetts General Hospital · P01 · FY2022 · CA
Human Mab Cocktails to Prevent & Treat H5N1 Avian Influenza
$1,430,391Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2011 · AI
STAMPOUT: A Phase 2a Study of Antibody for Methamphetamine Outpatient Therapy
$1,429,307Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2019 · DA
LIAI Epitope Validation Center: Characterization of Allergen specific T Cells
$1,429,182Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2016 · AI
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,428,684Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
BONE MARROW TRANSPLANTATION FOR BREAST CANCER
$1,428,619Duke University · P01 · FY2001 · CA
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
$1,428,421David E Fisher · Massachusetts General Hospital · P01 · FY2023 · CA
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
$1,428,130Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · U54 · FY2024 · CA
Understanding and Altering the Virologic Setpoint
$1,427,737Aaron Diamond Aids Research Center · U01 · FY2002 · AI
Cellular & Inflammatory Pathways in Ashtma & Allergic Diseases: From IgE to Cells
$1,427,642Lawrence Barry Schwartz · Virginia Commonwealth University · U19 · FY2011 · AI
Innate inflammatory responses during pulmonary infections
$1,427,583Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Functions and Mechanisms of NF-kB Factors and their Regulators
$1,427,118Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Cellular & Inflammatory Pathways in Ashtma & Allergic Diseases: From IgE to Cells
$1,426,933Lawrence Barry Schwartz · Virginia Commonwealth University · U19 · FY2012 · AI
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$1,423,817Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Engineering HCC-selective PET agent
$1,423,458Freddy Escorcia · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Cytokines and T Cell Development
$1,423,160Scott Durum · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Diagnosis, Pathophysiology And Molecular Biology of Pheochromocytoma and Paraganglioma
$1,422,979Karel Pacak · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Efficacy of a Nicotine Vaccine for Smoking Cessation
$1,421,797Matthew Hohenboken · Nabi Biopharmaceuticals · R01 · FY2007 · DA
Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)
$1,421,400Ana M Navarro · University Of California, San Diego · U54 · FY2008 · CA
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$1,420,204Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Research Project 2
$1,419,459Chong-Xian Pan · University Of California At Davis · U54 · FY2018 · CA